Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram and Chelated Zinc in Refractory Disseminated Melanoma
NCT02101008Phase 2Completed
- Sponsor
- University of Utah
- Start
- Mar 2010
- Primary completion
- Feb 2013
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of disulfiram, zinc gluconate in melanoma, sponsored by University of Utah. Started Mar 2010; status: completed.
02
Drugs
disulfiramzinc gluconate
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02101008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101008.